Archford Capital Strategies, LLC Bristol Myers Squibb CO Transaction History
Archford Capital Strategies, LLC
- $592 Million
- Q1 2024
A detailed history of Archford Capital Strategies, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Archford Capital Strategies, LLC holds 11,985 shares of BMY stock, worth $479,280. This represents 0.11% of its overall portfolio holdings.
Number of Shares
11,985
Previous 11,858
1.07%
Holding current value
$479,280
Previous $608,000
6.74%
% of portfolio
0.11%
Previous 0.11%
Shares
29 transactions
Others Institutions Holding BMY
# of Institutions
2,555Shares Held
1.49BCall Options Held
25.9MPut Options Held
20M-
Vanguard Group Inc Valley Forge, PA186MShares$7.44 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY163MShares$6.5 Billion0.21% of portfolio
-
State Street Corp Boston, MA91.6MShares$3.66 Billion0.23% of portfolio
-
Jpmorgan Chase & CO New York, NY88.8MShares$3.55 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$2.81 Billion0.79% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $85B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...